Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with KLRS: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
KLRS
Kalaris Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
KLRS
Kalaris Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No disclosed counterparties: KLRS.
Only KLRS
0
None
Role chip = supplier or customer
Source: SEC EDGAR
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.42
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
KLRS
Kalaris Therapeutics, Inc.
Change
2.48
▲
+5.08%
· post 2.48
Closed
Nov 6 '26
Mkt cap
$57.6M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
AMGN
Amgen Inc
vs
KLRS
Kalaris Therapeutics, Inc.
460.55
▲
+0.06%
post 460.42
Price
2.48
▲
+5.08%
post 2.48
$249.0B
Mkt cap
$57.6M
Q3 FY26
$10.4B
Revenue
—
FY25
$36.8B
Revenue
—
Change
Change
AMGN
460.55
▲
+0.06%
vs
KLRS
2.48
▲
+5.08%
Closed
Nov 6 '26